SAGAsafe®
Detects mutations, 100-fold improved compared to competing methods
Read MoreProducts
Whether the purpose is to find patients with specific mutations, monitoring therapeutic effect, measure residual disease or detect relapses, SAGA has developed ultrasensitive products for liquid and tissue biopsy testing.
SAGAsafe® and SAGAsign® are multipurpose and can be used across a patient’s journey, to monitor response to therapy, measure the change in tumor size, detect minimal residual disease, and aid in predicting prognosis and identifying targetable aberrations.